Interleukin-10 aerosol reduces proinflammatory mediators in bronchoalveolar fluid of endotoxemic rat

Critical Care Medicine

Volumn 33, Issue 10, 2005, Pages 2317-2322

  Hofstetter, Christian ^a   Flondor, Michael ^a   Hoegl, Sandra ^a   Muhl, Heiko ^a   Zwissler, Bernhard ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

Acute lung injury; Aerosol therapy; Alveolar macrophages; Anti inflammatory agents; Cytokines; Interieukin 10

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCOMPETENT CELL; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 26444502974     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000182815.78568.B2     Document Type: Article

References (26)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Fan J, Ye RD, Malik AB: Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1037-L1050
3. VanOtteren GM, Stricter RM, Kunkel SL, et al: Compartmentalized expression of RANTES in a murine model of endotoxemia. J Immunol 1995; 154:1900-1908
4. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022
5. Siler TM, Swierkosz JE, Hyers TM et al: Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res 1989; 15:881-894
6. Jacobs RF, Tabor DR, Burks AW, et al: Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140:1686-1692
7. Donnelly SC, Stricter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-647
8. Kobayashi A, Hashimoto S, Kooguci K, et al: Expression of inducible nitric oxide and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 1998; 113:1632-1639
9. Donnelly SC, Stricter RM, Reid PT, et al: The Association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125:191-196
10. Armstrong L, Millar A: Relative production of tumor necrosis factor alpha and interleukin-10 in adult respiratory distress syndrome. Thorax 1997; 52:442-446
11. Bernard GR, Wheeler AP, Naum CC et al: A placebo controlled, randomized trial of IL-10 in acute lung injury (ALI). Abstr. Chest 1999; 116:2608
12. Schulze A, Suguihara C, Gerhardt T, et al: Effects of respiratory mechanical unloading on thoracoabdominal motion in meconium-injured piglets and rabbits. Pediatr Res 1998; 43:191-197
13. Hofstetter C, Flondor M, Thein E, et al: Aerosol delivery during mechanical ventilation to the rat. Exp Lung Res 2004; 30:635-651
14. Ding AH, Nathan CF, Stuehr D: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:2407-2412
15. Smith PK, Krohn GT, Hermanson GT, et al: Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85
16. Sheldon MR, Fillyaw MY, Thompson WD: The use and interpretation of the Friedman test in the analysis of ordinal-scale data in repeated measures designs. Physiother Res Int 1996; 1:221-228
17. Howard M, Muchamuel T, Andrade S: Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208
18. Lo C-J, Fu M, Cryer HG: Interleukin-10 inhibits alveolar macrophage production of inflammatory mediators involved in adult respiratory distress syndrome. J Surg Res 1998; 79:179-184
19. Mulligan MS, Jones ML, Vaporciyan AA, et al: Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993; 151:5666-5674
20. Escofier N, Boichot E, Germain N, et al: Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam Clin Pharmacol 1999; 13:96-101
21. Zuany-Amorim C, Haile S, Leduc D, et al: Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95:2644-2651
22. Brain JD, Knudson DE, Sorokin SP, et al: Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 1976; 11:13-33
23. Inoue G: Effect of interleukin-10 (IL-10) on experimental LPS-induced acute lung injury. J Infect Chemother 2000; 6:51-60
24. Huhn RD, Radwanski E, O'Connell SM, et al: Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996; 87:699-705
25. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric synthase by interferon gamma in murine macrophages. Biochem Biophys Res Commun 1992; 182:1155-1159
26. Perretti M, Szabo C, Thiemermann C: Effect of interleukin-4 and interleukin-10 on leukocyte migration and nitrite oxide production in the mouse. Br J Pharmacol 1995; 116:2251-2257